News Updates
More Articles
- Benefits of Integrating Patient Engagement with Diversity, Equity, and Inclusion in New Medical Product Development: A Call for Action
- Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
- Fair Pay for Patient Engagement: Navigating the Evolving Landscape of Remuneration
- Industry’s Window to Express Interest in Africa Continental Product Evaluation Pilot Closes End of February 2024
- The Importance of Regulatory Due Diligence During the Acquisition Process
Choosing Inclusivity: Serving All Patients Through Scientifically Driven Eligibility Criteria
Lack of diversity in clinical trials can have a direct impact on health outcomes. Events of the past year and the pandemic have brought a renewed sense of urgency to ensure that underserved and understudied patient populations are not left behind in our age of personalized healthcare.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!